Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Relative Value
The Relative Value of one Shandong Pharmaceutical Glass Co Ltd stock under the Base Case scenario is 40 CNY. Compared to the current market price of 28.51 CNY, Shandong Pharmaceutical Glass Co Ltd is Undervalued by 29%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Shandong Pharmaceutical Glass Co Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
CN |
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
18.9B CNY | 3.9 | 25.6 | 21 | 21 | |
JP |
Hoya Corp
TSE:7741
|
6.4T JPY | 8.6 | 38.5 | 23.4 | 28.9 | ||
CH |
Alcon AG
SIX:ALC
|
35.5B CHF | 4.1 | 39.9 | 17.8 | 36.2 | ||
DK |
Coloplast A/S
CSE:COLO B
|
194.1B DKK | 7.8 | 39.9 | 26.2 | 30.4 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
23.2B USD | 6 | 52.1 | 27.8 | 33.8 | ||
US |
Cooper Companies Inc
NYSE:COO
|
17.7B USD | 4.8 | 60.7 | 22.3 | 37.8 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
14.3T KRW | 333.3 | -75.6 | -123.3 | -113.7 | |
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
56.7B CNY | 14.4 | 34.3 | 29.8 | 29.8 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.3B GBP | 3.1 | 50.7 | 46.8 | 50.9 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
6.3B USD | 1.6 | -48 | 12.2 | 26.3 | ||
CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.2B USD | 1.3 | -20 | 15.8 | 44.1 |